Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report

Abstract Background Fluconazole (FLCZ) inhibits cytochrome P450 (CYP) 2C9, 2C19, and 3A4 and has a drug-drug interaction that potentiates the effects of warfarin and prolong the prothrombin time-international normalized ratio (PT-INR). Although a drug-drug interaction have been reported between FLCZ...

Full description

Bibliographic Details
Main Authors: Hayato Akamatsu, Hiroo Nakagawa, Ichiro Matsumaru, Junya Hashizume, Hitomi Harasawa, Yukinobu Kodama, Takashi Miura, Kaname Ohyama
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Online Access:https://doi.org/10.1186/s40780-023-00279-w
_version_ 1797853645907165184
author Hayato Akamatsu
Hiroo Nakagawa
Ichiro Matsumaru
Junya Hashizume
Hitomi Harasawa
Yukinobu Kodama
Takashi Miura
Kaname Ohyama
author_facet Hayato Akamatsu
Hiroo Nakagawa
Ichiro Matsumaru
Junya Hashizume
Hitomi Harasawa
Yukinobu Kodama
Takashi Miura
Kaname Ohyama
author_sort Hayato Akamatsu
collection DOAJ
description Abstract Background Fluconazole (FLCZ) inhibits cytochrome P450 (CYP) 2C9, 2C19, and 3A4 and has a drug-drug interaction that potentiates the effects of warfarin and prolong the prothrombin time-international normalized ratio (PT-INR). Although a drug-drug interaction have been reported between FLCZ and warfarin, the effects of the timing of their administration on this interaction have not yet been investigated. Case presentation A female patient in her 30s with Marfan syndrome had undergone the Bentall procedure with a mechanical valve and total arch replacement for acute aortic dissection Stanford A type and rupture of the ascending aorta. Warfarin was administered to prevent thromboembolism. She was hospitalized 1 year ago for graft infection caused by Candida albicans, and treatment with FLCZ was initiated. She received FLCZ 200 mg once a day in the morning and warfarin 1.75 mg once a day in the evening, and the PT-INR remained stable at approximately 2.0 and within the therapeutic range. However, 42 days after changing the timing of administration of warfarin from evening to morning, the PT-INR was prolonged by approximately 3-fold to 6.25. The PT-INR then decreased to the previous level by changing the timing of administration of warfarin from morning to evening. Conclusions The timing of administration of FLCZ and warfarin may affect the magnitude of drug-drug interaction.
first_indexed 2024-04-09T19:54:02Z
format Article
id doaj.art-49217e61f0364a39ac3252d608d4a5ee
institution Directory Open Access Journal
issn 2055-0294
language English
last_indexed 2024-04-09T19:54:02Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Journal of Pharmaceutical Health Care and Sciences
spelling doaj.art-49217e61f0364a39ac3252d608d4a5ee2023-04-03T05:34:44ZengBMCJournal of Pharmaceutical Health Care and Sciences2055-02942023-04-01911410.1186/s40780-023-00279-wEffects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case reportHayato Akamatsu0Hiroo Nakagawa1Ichiro Matsumaru2Junya Hashizume3Hitomi Harasawa4Yukinobu Kodama5Takashi Miura6Kaname Ohyama7Department of Hospital Pharmacy, Nagasaki University HospitalDepartment of Hospital Pharmacy, Nagasaki University HospitalDepartment of Cardiovascular Surgery, Nagasaki University HospitalDepartment of Hospital Pharmacy, Nagasaki University HospitalDepartment of Hospital Pharmacy, Nagasaki University HospitalDepartment of Hospital Pharmacy, Nagasaki University HospitalDepartment of Cardiovascular Surgery, Nagasaki University HospitalDepartment of Hospital Pharmacy, Nagasaki University HospitalAbstract Background Fluconazole (FLCZ) inhibits cytochrome P450 (CYP) 2C9, 2C19, and 3A4 and has a drug-drug interaction that potentiates the effects of warfarin and prolong the prothrombin time-international normalized ratio (PT-INR). Although a drug-drug interaction have been reported between FLCZ and warfarin, the effects of the timing of their administration on this interaction have not yet been investigated. Case presentation A female patient in her 30s with Marfan syndrome had undergone the Bentall procedure with a mechanical valve and total arch replacement for acute aortic dissection Stanford A type and rupture of the ascending aorta. Warfarin was administered to prevent thromboembolism. She was hospitalized 1 year ago for graft infection caused by Candida albicans, and treatment with FLCZ was initiated. She received FLCZ 200 mg once a day in the morning and warfarin 1.75 mg once a day in the evening, and the PT-INR remained stable at approximately 2.0 and within the therapeutic range. However, 42 days after changing the timing of administration of warfarin from evening to morning, the PT-INR was prolonged by approximately 3-fold to 6.25. The PT-INR then decreased to the previous level by changing the timing of administration of warfarin from morning to evening. Conclusions The timing of administration of FLCZ and warfarin may affect the magnitude of drug-drug interaction.https://doi.org/10.1186/s40780-023-00279-wFluconazoleWarfarinPT-INRDrug-drug interactionTiming of administration
spellingShingle Hayato Akamatsu
Hiroo Nakagawa
Ichiro Matsumaru
Junya Hashizume
Hitomi Harasawa
Yukinobu Kodama
Takashi Miura
Kaname Ohyama
Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
Journal of Pharmaceutical Health Care and Sciences
Fluconazole
Warfarin
PT-INR
Drug-drug interaction
Timing of administration
title Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
title_full Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
title_fullStr Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
title_full_unstemmed Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
title_short Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
title_sort effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the pt inr a case report
topic Fluconazole
Warfarin
PT-INR
Drug-drug interaction
Timing of administration
url https://doi.org/10.1186/s40780-023-00279-w
work_keys_str_mv AT hayatoakamatsu effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT hiroonakagawa effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT ichiromatsumaru effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT junyahashizume effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT hitomiharasawa effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT yukinobukodama effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT takashimiura effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport
AT kanameohyama effectsofchangingthetimingofwarfarinadministrationincombinationwithfluconazoleonprolongationoftheptinracasereport